The recent decisions by two of the most influential national newspapers of record to not publish their endorsements of Vice President Kamala Harris says a lot about how seriously they take Trump’s threats to democracy and his promises of vengeance against his enemies.
biotech
Follow:
-
3 Things to Know Ahead of the Global March Against Monsanto
Despite the funding with which it shapes public policy and tries to prevent GMO labeling, and its overall reckless corporate behavior, Monsanto is nothing compared to the power of the consumer at large.
-
Monsanto Spends $4.6 Million to Defeat Washington GMO Labeling Initiative
The campaign for Washington's GMO-labeling initiative is looking a lot like last year's Prop 37 campaign in California, where biotech and agribusiness interests outspent the other side by nearly 5 to 1.
-
In Europe, March Against Monsanto Is Latest Rejection of the GMO Giant
Momentum is building across Europe, country by country and region by region, to outlaw the biotech giant.
-
How the Monsanto Protection Act Became Law
This week, Monsanto its lobbyists successfully shoved through legislation that effectively makes oversight of GMO food void.
-
Revealed: "Monsanto Protection Act" Trumps U.S. Government
Monsanto snuck a "rider" last week into the latest Senate agricultural legislation, giving the biotech giant blanket immunity from USDA action to halt potentially harmful GMO crops.
